XML 91 R64.htm IDEA: XBRL DOCUMENT v3.24.1
Other income and expenses - net (Details)
$ in Millions
12 Months Ended
Dec. 28, 2023
EUR (€)
tranche
Dec. 28, 2023
USD ($)
tranche
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 28, 2023
USD ($)
Dec. 31, 2020
EUR (€)
analysis of information related to sale of subsidiary.              
Foreign exchange gains (losses)     € (942,000) € 99,000 € 125,000    
Income from government grants     220,000 563,000 344,000    
Research collaborations where costs are shared equally     1,019,000 898,000 1,072,000    
Cash and cash equivalents     € 38,529,000 € 190,286,000 € 197,630,000   € 146,854,000
AbCheck              
analysis of information related to sale of subsidiary.              
Gross purchase price € 5,800,000         $ 6.4  
Consideration in cash to be paid € 4,900,000         5.4  
Number of tranches for cash paid | tranche 2 2          
Share subject to certain adjustments € 900,000         $ 1.0  
Purchase price had been received 1,600,000 $ 1.8          
Gain (loss) recognized on other income 4,300,000 $ 4.8          
Cash and cash equivalents 642,000            
AbCheck | Bottom of range              
analysis of information related to sale of subsidiary.              
Adjustment To Ampersand Shares € 300,000